Diagnosis and management of portal vein thrombosis in patients with cirrhosis of liver

  • Logan Adams
  • Somedeb Ball
Keywords: portal vein thrombosis, cirrhosis, anticoagulation, portal hypertension

Abstract

Portal vein thrombosis (PVT) is an occlusion of the portal venous system and is a common complication of liver cirrhosis. It can present as either an acute or chronic complication. Acute PVT can present with abdominal pain, diarrhea, ileus, and bleeding. Chronic PVT is often asymptomatic; however, it can be discovered in cases of worsening portal hypertension. Portal vein thrombosis is diagnosed by imaging modalities, such as ultrasound and computed tomography. Contrast-enhanced imaging can be used in cases with difficult visualization. Despite the hemostatic imbalance in cirrhosis, anticoagulants can be safely used to recanalize the vein. Transjugular intrahepatic portosystemic shunt procedures are also an effective method for recanalization.

References

Primignani M. Portal vein thrombosis, revisited. Digestive Liver Disease 2010;42:163–70.

Tsochatzis EA, Senzolo M, Germani G, et al. Systematic review: portal vein thrombosis in cirrhosis. Alimentary Pharmacology Therapeutics 2010;31(3):366–74.

Francoz C, Belghiti J, Vilgrain V, et al. Splanchnic vein thrombosis in candidates for liver transplantation: usefulness of screening and anticoagulation. Gut 2005;54(5):691–7.

Nonami T, Yokoyama I, Iwatsuki S, et al. The incidence of portal vein thrombosis at liver transplantation. Hepatology (Baltimore, Md) 1992;16(5):1195–8.

Hernández-Conde M, Llop E, De-La-Revilla J, et al. Prevalence and outcome of portal thrombosis in a cohort of cirrhotic patients undergoing liver transplantation. Rev esp enferm dig 2016;108(11):716–20.

Violi F, Corazza RG, Caldwell SH, et al. Portal vein thrombosis relevance on liver cirrhosis: Italian Venous Thrombotic Events Registry. Internal Emergency Med 2016;11(8):1059–66.

Stine JG, Shah PM, Cornella SL, et al. Portal vein thrombosis, mortality and hepatic decompensation in patients with cirrhosis: A meta-analysis. World J Hepatology 2015;7(27):2774–80.

Rodríguez-Castro KI, Porte RJ, Nadal E, et al. Management of nonneoplastic portal vein thrombosis in the setting of liver transplantation. Transplantation J 2012;94(11):1145–53.

Borjas-Almaguer OD, Cortez-Hernández CA, González-Moreno EI, et al. Portal vein thrombosis in patients with cirrhosis: just a common finding or a predictor of poor outcome? Ann Hepatol 2016;15(6):902–6.

Andriulli A, Tripodi A, Angeli P, et al. Hemostatic balance in patients with liver cirrhosis: Report of a consensus conference. Digestive Liver Dis 2016;48:455–67.

Seo YS, Shah VH. The role of gut-liver axis in the pathogenesis of liver cirrhosis and portal hypertension. Clinical Molecular Hepatology 2012;18(4):337–46.

Carnevale R, Raparelli V, Nocella C, et al. Gut-derived endotoxin stimulates factor VIII secretion from endothelial cells. Implications for hypercoagulability in cirrhosis. J Hepatology 2017;67(5):950–6.

Ventura P, Venturelli G, Marcacci M, et al. Hyperhomocysteinemia and MTHFR C677T polymorphism in patients with portal vein thrombosis complicating liver cirrhosis. Thrombosis Res 2016;141:189–95.

Shin KH, Kim IS, Lee HJ, et al. Thromboelastographic evaluation of coagulation in patients with liver disease. Annals Laboratory Med 2017;37(3):204–12.

De Pietri L, Bianchini M, Rompianesi G, et al. Thromboelastographic reference ranges for a cirrhotic patient population undergoing liver transplantation. World J Transplantation 2016;6(3):583–93.

Lloyd-Donald P, Vasudevan A, Angus P, et al. Coagulation in acutely ill patients with severe chronic liver disease: Insights from thromboelastography. J Critical Care 2017;38:215–24.

Loudin M, Ahn J. Portal vein thrombosis in cirrhosis. J Clinical Gastroenterology 2017;51(7):579–85.

Yerdel MA, Gunson B, Mirza D, et al. Portal vein thrombosis in adults undergoing liver transplantation: risk factors, screening, management, and outcome. Transplantation 2000;69(9):1873–81.

Sarin SK, Philips CA, Kamath PS, et al. Toward a comprehensive new classification of portal vein thrombosis in patients with cirrhosis. Gastroenterology 2016;151(4):574–577.e3.

Margini C, Berzigotti A. Portal vein thrombosis: The role of imaging in the clinical setting. Digestive Liver Dis 2017;49(2):113–20.

Danilă M, Sporea I, Popescu A, et al. Portal vein thrombosis in liver cirrhosis – the added value of contrast enhanced ultrasonography. Medical Ultrasonography 2016;18(2):218.

Hidajat N, Stobbe H, Griesshaber V, et al. Imaging and radiological interventions of portal vein thrombosis. Acta Radiologica (Stockholm, Sweden : 1987) 2005;46(4):336–43.

Shimada K, Isoda H, Okada T, et al. Non-contrast-enhanced MR portography with time-spatial labeling inversion pulses: comparison of imaging with three-dimensional half-fourier fast spin-echo and true steady-state free-precession sequences. J Magnetic Resonance Imaging 2009;29(5):1140–6.

Ohno T, Isoda H, Furuta A, et al. Non-contrast-enhanced MR portography and hepatic venography with time-spatial labeling inversion pulses: comparison at 1.5 Tesla and 3 Tesla. Acta Radiologica Short Reports 2015;4(5):205846011558411.

Kiladjian J-J, Cervantes F, Leebeek FWG, et al. The impact of JAK2 and MPL mutations on diagnosis and prognosis of splanchnic vein thrombosis: a report on 241 cases. Blood 2008;111(10):4922–9.

Villa E, Cammà C, Marietta M, et al. Enoxaparin prevents portal vein thrombosis and liver decompensation in patients with advanced cirrhosis. Gastroenterology 2012;143(5):1253–1260.e4.

Mancuso A. Management of portal vein thrombosis in cirrhosis. European J Gastroenterology Hepatology 2016;28(7):739–43.

Mancuso A. The ischemic liver cirrhosis theory and its clinical implications. Medical Hypotheses 2016;94:4–6.

Loffredo L, Pastori D, Farcomeni A, et al. Effects of anticoagulants in patients with cirrhosis and portal vein thrombosis: a systematic review and meta-analysis. Gastroenterology 2017;153(2):480–487.e1.

Qi X, De Stefano V, Li H, et al. Anticoagulation for the treatment of portal vein thrombosis in liver cirrhosis: a systematic review and meta-analysis of observational studies. European J Int Med 2015;26(1):23–9.

Naeshiro N, Aikata H, Hyogo H, et al. Efficacy and safety of the anticoagulant drug, danaparoid sodium, in the treatment of portal vein thrombosis in patients with liver cirrhosis. Hepatology Res 2015;45(6):656–62.

Nagaoki Y, Aikata H, Daijyo K, et al. Efficacy and safety of edoxaban for treatment of portal vein thrombosis following danaparoid sodium in patients with liver cirrhosis. Hepatology Res 2018;48(1):51–8.

De Gottardi A, Trebicka J, Klinger C, et al. Antithrombotic treatment with direct-acting oral anticoagulants in patients with splanchnic vein thrombosis and cirrhosis. Liver International 2017;37(5):694–9.

Hum J, Shatzel JJ, Jou JH, et al. The efficacy and safety of direct oral anticoagulants vs traditional anticoagulants in cirrhosis. European J Haematology 2017;98(4):393–7.

Senzolo M, M. Sartori T, Rossetto V, et al. Prospective evaluation of anticoagulation and transjugular intrahepatic portosistemic shunt for the management of portal vein thrombosis in cirrhosis. Liver International 2012;32(6):919–27.

Delgado MG, Seijo S, Yepes I, et al. Efficacy and safety of anticoagulation on patients with cirrhosis and portal vein thrombosis. Clinical gastroenterology and hepatology 2012;10(7):776–83.

Luca A, Miraglia R, Caruso S, et al. Short- and long-term effects of the transjugular intrahepatic portosystemic shunt on portal vein thrombosis in patients with cirrhosis. Gut 2011;60(6):846–52.

Wang Z, Jiang M-S, Zhang H-L, et al. Is post-TIPS anticoagulation therapy necessary in patients with cirrhosis and portal vein thrombosis? a randomized controlled trial. Radiology 2016;279(3):943–51.

Turon F, Hernández-Gea V, García-Pagán JC. Portal vein thrombosis: yes or no on anticoagulation therapy. Current Opinion Organ Transplantation 2018;23(2):250–6.

Thornburg B, Desai K, Hickey R, et al. Pretransplantation portal vein recanalization and transjugular intrahepatic portosystemic shunt creation for chronic portal vein thrombosis: final analysis of a 61-patient cohort. J Vascular Interventional Radiology 2017;28(12):1714–1721.e2.

Thornburg B, Desai K, Hickey R, et al. Portal vein recanalization and transjugular intrahepatic portosystemic shunt creation for chronic portal vein thrombosis: technical considerations. Techniques Vascular Interventional Radiology 2016;19(1):52–60.

Published
2018-10-19
How to Cite
Adams, L., & Ball, S. (2018). Diagnosis and management of portal vein thrombosis in patients with cirrhosis of liver. The Southwest Respiratory and Critical Care Chronicles, 6(26), 10-16. https://doi.org/10.12746/swrccc.v6i26.496